Arch Therapeutics (OTC: ARTH)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Arch Therapeutics (OTCQB: ARTH) through any online brokerage.
There are no as such competitors for Arch Therapeutics.
The latest price target for Arch Therapeutics (OTCQB: ARTH) was reported by HC Wainwright & Co. on Monday, July 27, 2020. The analyst firm set a price target for 1.50 expecting ARTH to rise to within 12 months (a possible 2961.22% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Arch Therapeutics (OTCQB: ARTH) is $0.049 last updated July 1, 2022, 7:32 PM UTC.
There are no upcoming dividends for Arch Therapeutics.
Arch Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Arch Therapeutics.
Arch Therapeutics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the OTCQB.